SIM
MDGL icon

Strategic Investment Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Strategic Investment Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,452
Closed -$134K – 126
2014
Q4 		$134K Buy
1,452
+596
+70% +$61.6K 0.04% 85
2014
Q3 		$90K Buy
+856
New +$119K 0.03% 96

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Strategic Investment Management's MDGL Position: Q1 2015 in Review

Strategic Investment Management sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2015, closing a stake of 1,452 shares — an estimated $134K sold.

Strategic Investment Management first reported a position in MDGL in Q3 2014 and held it in 2 quarters. The position peaked at $134K in Q4 2014. 91 funds tracked by Wall St. Rank hold MDGL as of Q1 2015.

  • Strategic Investment Management reported no remaining Madrigal Pharmaceuticals position as of Q1 2015 after selling out during the quarter.
  • Strategic Investment Management sold 1,452 Madrigal Pharmaceuticals shares in Q1 2015, an estimated $134K.
  • Strategic Investment Management first reported a position in Madrigal Pharmaceuticals in Q3 2014 and held it in 2 quarters.
  • Strategic Investment Management's Madrigal Pharmaceuticals position peaked at $134K in Q4 2014.
  • 91 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2015.

Based on Strategic Investment Management's 13F filing for Q1 2015, filed 14 May 2015.